Drug Discovery News and Research

RSS
The drug discovery process begins with recognizing a disease or clinical condition in which there is a lack of adequate medical treatment. Once a potential drug has been identified, pre-clinical research can begin. This process includes several stages; the first of which involves identifying and validating the prospective drug’s target through assay development, high throughput screening, hit identification and finally, lead optimization. Once the pre-clinical process is complete, the newly synthesized drug candidate is selected for future clinical development.
Molecular motion of “undruggable” proteins reveals drug-binding sites

Molecular motion of “undruggable” proteins reveals drug-binding sites

Optibrium appoints Ian Smith as Chief Technology Officer

Optibrium appoints Ian Smith as Chief Technology Officer

Providing structural understanding of the influenza virus

Providing structural understanding of the influenza virus

New bioprinting platform to replicate tumors in 3D spheroids

New bioprinting platform to replicate tumors in 3D spheroids

Drug discovery method facilitates promising treatment approaches for metabolic diseases

Drug discovery method facilitates promising treatment approaches for metabolic diseases

PhoreMost enters multi-project drug target discovery collaboration with Roche

PhoreMost enters multi-project drug target discovery collaboration with Roche

Detecting multiple food poisoning bacteria based on color differences in scattered light from metals

Detecting multiple food poisoning bacteria based on color differences in scattered light from metals

Inventia Life Science Accelerates Growth with AU$35 million Series B Led by Blackbird Ventures, Launching 3D Cell Culture Platform into US Market

Inventia Life Science Accelerates Growth with AU$35 million Series B Led by Blackbird Ventures, Launching 3D Cell Culture Platform into US Market

Australian company accelerating the speed of drug discovery wins prestigious Eureka prize

Australian company accelerating the speed of drug discovery wins prestigious Eureka prize

Inventia Life Science partners with Xylyx Bio to develop tissue-specific, digitally-printed bioinks for drug discovery

Inventia Life Science partners with Xylyx Bio to develop tissue-specific, digitally-printed bioinks for drug discovery

RASTRUM™ - the 3D Printer of Living Cells, Honored in Annual Awards by Leading Business Magazine

RASTRUM™ - the 3D Printer of Living Cells, Honored in Annual Awards by Leading Business Magazine

Inventia Life Science Announces Partnership with PhenoVista Biosciences to Accelerate Preclinical Research with 3D Cell Models

Inventia Life Science Announces Partnership with PhenoVista Biosciences to Accelerate Preclinical Research with 3D Cell Models

Sample management innovation on tour

Sample management innovation on tour

CN Bio opens new laboratory facilities to extend Organ-on-a-chip contract research services capabilities

CN Bio opens new laboratory facilities to extend Organ-on-a-chip contract research services capabilities

New technique enables researchers to pinpoint protein–drug interaction

New technique enables researchers to pinpoint protein–drug interaction

Challenges in Drug Discovery; Where are we now, and where are we going?

Challenges in Drug Discovery; Where are we now, and where are we going?

How Important is the European Ecosystem to Life Sciences Research?

How Important is the European Ecosystem to Life Sciences Research?

How can High-Content Screening accelerate Drug Discovery?

How can High-Content Screening accelerate Drug Discovery?

New biomedical research tool may help advance molecular diagnostics and drug discovery

New biomedical research tool may help advance molecular diagnostics and drug discovery

Integrating Science, Software, and Data to Accelerate Antibody Discovery

Integrating Science, Software, and Data to Accelerate Antibody Discovery